About this Journal Submit a Manuscript Table of Contents
ISRN Surgery
Volume 2012 (2012), Article ID 513241, 6 pages
http://dx.doi.org/10.5402/2012/513241
Clinical Study

Locally Advanced Pancreatic Head Cancer: Margin-Positive Resection or Bypass?

Department of General and Visceral Surgery, University of Freiburg, Hugstetter Street 55, 79106 Freiburg, Germany

Received 26 January 2012; Accepted 29 April 2012

Academic Editors: A. Parry and B. H. Yong

Copyright © 2012 Ulrich Friedrich Wellner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Gillen, T. Schuster, C. M. Z. Büschenfelde, H. Friess, and J. Kleeff, “Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages,” PLoS Medicine, vol. 7, no. 4, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. F. Yekebas, D. Bogoevski, G. Cataldegirmen et al., “En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients,” Annals of Surgery, vol. 247, no. 2, pp. 300–309, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Riediger, F. Makowiec, E. Fischer, U. Adam, and U. T. Hopt, “Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection,” Journal of Gastrointestinal Surgery, vol. 10, no. 8, pp. 1106–1115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Lavu, A. A. Mascaro, D. R. Grenda et al., “Margin positive pancreaticoduodenectomy is superior to palliative bypass in locally advanced pancreatic ductal adenocarcinoma.,” Journal of Gastrointestinal Surgery, vol. 13, no. 11, pp. 1937–1946, 2009. View at Publisher · View at Google Scholar
  5. G. Fusai, N. Warnaar, C. A. Sabin, S. Archibong, and B. R. Davidson, “Outcome of R1 resection in patients undergoing pancreatico-duodenectomy for pancreatic cancer,” European Journal of Surgical Oncology, vol. 34, no. 12, pp. 1309–1315, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Kuhlmann, S. De Castro, T. Van Heek et al., “Microscopically incomplete resection offers acceptable palliation in pancreatic cancer,” Surgery, vol. 139, no. 2, pp. 188–196, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. K. D. Lillemoe, J. L. Cameron, J. M. Hardacre et al., “Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial,” Annals of Surgery, vol. 230, no. 3, pp. 322–330, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. K. D. Lillemoe, J. L. Cameron, C. J. Yeo et al., “Pancreaticoduodenectomy: does it have a role in the palliation of pancreatic cancer?” Annals of Surgery, vol. 223, no. 6, pp. 718–728, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. S. V. Shrikhande, J. Kleeff, C. Reiser et al., “Pancreatic resection for M1 pancreatic ductal adenocarcinoma,” Annals of Surgical Oncology, vol. 14, no. 1, pp. 118–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. G. D. Kymionis, M. M. Konstadoulakis, E. Leandros et al., “Effect of curative versus palliative surgical treatment for stage III pancreatic cancer patients,” Journal of the Royal College of Surgeons of Edinburgh, vol. 44, no. 4, pp. 231–235, 1999. View at Scopus
  11. L. A. Di Fronzo, J. Cymerman, S. Egrari, and T. X. O'Connell, “Unresectable pancreatic carcinoma: correlating length of survival with choice of palliative bypass,” American Surgeon, vol. 65, no. 10, pp. 955–958, 1999. View at Scopus
  12. E. N. Scott, G. Garcea, H. Doucas, W. P. Steward, A. R. Dennison, and D. P. Berry, “Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma,” Journal of the International Hepato Pancreato Biliary Association, vol. 11, no. 2, pp. 118–124, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Schwarz and H. G. Beger, “Biliary and gastric bypass or stenting in nonresectable periampullary cancer: analysis on the basis of controlled trials,” International Journal of Pancreatology, vol. 27, no. 1, pp. 51–58, 2000. View at Scopus
  14. M. C. Taylor, R. S. McLeod, and B. Langer, “Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: a meta-analysis,” Liver Transplantation, vol. 6, no. 3, pp. 302–308, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. I. Esposito, J. Kleeff, F. Bergmann et al., “Most pancreatic cancer resections are R1 resections,” Annals of Surgical Oncology, vol. 15, no. 6, pp. 1651–1660, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. N. B. Jamieson, A. K. Foulis, K. A. Oien et al., “Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma,” Annals of Surgery, vol. 251, no. 6, pp. 1003–1010, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. K. V. Menon, D. Gomez, A. M. Smith, A. Anthoney, and C. S. Verbeke, “Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP),” Journal of the International Hepato Pancreato Biliary Association, vol. 11, no. 1, pp. 18–24, 2009. View at Publisher · View at Google Scholar · View at Scopus